| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.8 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |